Opioid Addiction Epidemic Lawsuits Pile Up

Thanksgiving is now behind us, and we hope you made it through the holiday drug and alcohol-free. At Celebrate Hope, we understand how challenging it is to navigate holidays in recovery. Every holiday celebrated clean and sober is a remarkable accomplishment worth acknowledging. 

 

We wanted to take a moment to follow up on a previous story covered recently on our blog regarding Purdue Pharma—the maker of OxyContin. As we shared in an article last month, Purdue agreed to plead guilty to criminal charges regarding its role in the American opioid addiction epidemic. As part of the settlement with the Justice Department, the pharmaceutical giant also agreed to face penalties of about $8.3 billion. 

 

Purdue pleaded guilty to the criminal charges two days before Thanksgiving, The New York Times reports. During the November 24th hearing, Purdue admitted to misleading the federal government about OxyContin sales. 

 

Purdue’s chairman, Steve Miller, conceded that the company was marketing the potent narcotic to over 100 physicians suspected of illegally prescribing the drug. What’s more, Purdue pleaded guilty to paying doctors illegal kickbacks for prescribing OxyContin. Thus concludes the federal government’s case against the pharmaceutical company.  

“The abuse and diversion of prescription opioids has contributed to a national tragedy of addiction and deaths,” said Jeffrey A. Rosen, the deputy attorney general. “Today’s convictions underscore the department’s commitment to its multipronged strategy for defeating the opioid crisis.” 

 

We want to remind our readers that there are thousands of pending lawsuits against Purdue. Purdue’s guilty plea does not shield the company from the suits brought by state and local governments. Moreover, Purdue is just one company that contributed to the opioid epidemic; many companies had a hand in the more than 450,000 American deaths since 1999. 

 

Many Players Involved in the Opioid Addiction Epidemic

 

Just as Purdue turned a blind eye to the devastation caused by OxyContin, so too did other narcotic makers and the companies that distribute such drugs. Pharmacies and the companies that distribute to them are also facing thousands of lawsuits. 

 

Johnson & Johnson and three drug distributors are hashing out a $26 billion deal with state and local governments for their hand in the opioid addiction epidemic, according to The New York Times. The distributors involved in the negotiations are McKesson, Cardinal Health, AmerisourceBergen. If an agreement is reached, it will shield the four companies from future lawsuits by these governments. 

 

Prescription opioids had a hand in more than 232,000 American deaths from 1999 to 2018, according to the Centers for Disease Control and Prevention. More than three-quarters of the nation’s opioids shipped to pharmacies came from the three distributors listed above, the article reports. If approved by the governments involved in the lawsuits, most of the $26 billion would go towards treatment and prevention in areas severely impacted by opioids. 

 

“The deal gets money to all of the communities in the United States that are suffering from insult upon injury, first from the opioid epidemic and now with COVID as well,” said Paul J. Hanly Jr., an attorney who represents numerous small governments. “We believe it’s in the best interest of these communities to begin receiving a payment stream. We looked at the finances of these companies and believe the numbers are now appropriate.”

 

California Faith-Based Addiction Treatment

 

If you or a loved one struggles with opioid use disorder, please contact Celebrate Hope to learn more about our faith-based addiction treatment program. Our team helps men and women break the cycle of addiction and begin anew. We rely on the teachings of Jesus Christ, along with evidence-based therapies to get individuals on the path of recovery.

OxyContin and Opioid Epidemic Settlement

When discussing the American opioid addiction epidemic, the name OxyContin is synonymous. The brand name of oxycodone, a powerful prescription opioid, is closely associated with our toxic relationship with painkillers in the United States. 

 

Even people who've never been prescribed an opioid are familiar with OxyContin. The drug was prescribed by doctors in large amounts from the mid-nineties onward. The drugmaker – Purdue Pharma – marketed OxyContin as safe for users; the company contended that it carried a low risk of addiction. 

 

Now 25 years later and tens of thousands of overdose deaths, OxyContin is anything but safe when prescribed in high doses for protracted periods. What's more, most of today's heroin users were introduced to opioids via drugs like oxycodone. Around 80 percent of people using heroin started down the path of opioid use disorder with prescription painkillers. 

 

In recent years, the prescription drug industry or "big pharma" has been asked to account for its role in creating the public health crisis we face today. From doctors to drug distributors to the makers of the drugs themselves, many entities are in the hot seat for the more than 450,000 Americans who have died from an overdose since 1999. 

 

While heroin and illicit fentanyl – a drug 100 times more potent than morphine – dominate the headlines today, the epidemic's origin goes back to rampant overprescribing dating back to the 1990s. According to the Centers for Disease Control and Prevention (CDC), many doctors continue to prescribe high doses of oxycodone across the country more than two decades later. 

 

In 2017, there were still almost 58 opioid prescriptions written for every 100 Americans; more than 17% of Americans had at least one opioid medication filled. More than 191 million opioid prescriptions were dispensed to Americans that year. 

 

OxyContin Maker Held Accountable

 

Last month, the U.S Justice Department and Purdue Pharma agreed regarding its role in the opioid epidemic. The pharmaceutical giant agreed to plead guilty to criminal charges and face penalties of around $8.3 billion, The New York Times reports. Members of the Sackler family – the owners of Purdue Pharma – agreed to pay $225 million in civil penalties. 

 

Purdue will plead guilty to felony charges of defrauding federal health agencies and violating anti-kickback laws, according to the article. The company will be ordered to pay $3.54 billion in criminal fines, $2.8 billion in civil penalties for violating the False Claims Act, and $2 billion in criminal forfeiture of profits. 

 

It's worth noting that there are thousands of pending lawsuits against Purdue Pharma. The agreement with the justice department could pave the way to a resolution in many of those cases. Steve Miller, chairman of the company board, said: 

 

"Purdue deeply regrets and accepts responsibility for the misconduct detailed by the Department of Justice in the agreed statement of facts." 

 

While more than $8 billion is a lot of money, there is little indication that the company will pay anything close to that because it filed for bankruptcy court protection when the lawsuits started piling up. What's more, there are some who feel that the agreement does not go far enough even though it did not preclude the filing of criminal charges against Purdue executives or members of the Sackler family. Maura Healey, the Massachusetts attorney general, said: 

 

"The D.O.J. failed. Justice in this case requires exposing the truth and holding the perpetrators accountable, not rushing a settlement to beat an election. I am not done with Purdue and the Sacklers, and I will never sell out the families who have been calling for justice for so long." 

 

Massachusetts is moving forward with depositions against the Sacklers this month. It will be interesting to see how the cases against Purdue Pharma plays out. It could set a precedent; it is not the only company facing lawsuits for impropriety related to prescription opioids. 

 

Opioid Use Disorder Treatment

 

Please reach out to Celebrate Hope if you are struggling with prescription opioid or heroin addiction. We can help you break the cycle of addiction and get on the path toward healing. Opioid use disorder is treatable and recovery is possible